Posted by Michael Wonder on 24 Aug 2023
Nectero Medical receives FDA fast track designation for Nectero EAST System
24 August 2023 - Fast Track designation accelerates Nectero EAST System’s path to FDA regulatory review of a treatment for patients with small to mid-sized abdominal aortic aneurysms.
Nectero Medical today announced that the US FDA has granted fast track designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST) System to treat patients with infrarenal AAAs, maximum diameter 3.5 – 5.0 cm.
